Back
Berkshire Hathaway Vs. Akero Therapeutics Industry Stock Comparison
Sell
37
BRK.A
Berkshire Hathaway
Last Price:
602,000.00
Seasonality Move:
3.24%
Sell
25
AKRO
Akero Therapeutics
Last Price:
19.95
Seasonality Move:
16.15%
Sell
37
Berkshire Hathaway (BRK.A)
is a Sell
Is Berkshire Hathaway a Buy, Sell or Hold?
- The current Berkshire Hathaway [BRK.A] share price is $602,100.01. The Score for BRK.A is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- BRK.A is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $20.08. The Score for AKRO is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- AKRO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BRK.A Stock Price Chart
What is Berkshire Hathaway's stock price today?
-
The Berkshire Hathaway share price today is $602,100.01
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BRK.A is experiencing slight buying pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $20.08
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight selling pressure.
BRK.A Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3570.81 | Sell |
| Relative Strength Index (14 RSI): | 40.24 | Sell |
| Chaikin Money Flow: | 917 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (616428.04 - 616452.04) | Sell |
| Bollinger Bands (100): | (591032.94 - 591092.94) | Buy |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.25 | Sell |
| Relative Strength Index (14 RSI): | 37.2 | Sell |
| Chaikin Money Flow: | -178163 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.19 - 23.49) | Sell |
| Bollinger Bands (100): | (20.21 - 26.05) | Sell |
BRK.A Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 608932.38 | Sell |
| 20-day SMA: | 612436.65 | Sell |
| 50-day SMA: | 616465.42 | Sell |
| 200-day SMA: | 563772.96 | Buy |
| 8-day EMA: | 606291.42 | Sell |
| 20-day EMA: | 610867.97 | Sell |
| 50-day EMA: | 608809.4 | Sell |
| 200-day EMA: | 567764.94 | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.04 | Buy |
| 20-day SMA: | 21.29 | Sell |
| 50-day SMA: | 24.49 | Sell |
| 200-day SMA: | 28.44 | Sell |
| 8-day EMA: | 20.14 | Sell |
| 20-day EMA: | 21.28 | Sell |
| 50-day EMA: | 22.72 | Sell |
| 200-day EMA: | 27.22 | Sell |
Berkshire Hathaway Earnings Growth & BRK.A Earnings Dates
- Analysts estimate an earnings increase this quarter of $545.13 per share, an increase next quarter of $251.87 per share, an increase this year of $5,235.29 per share, and an increase next year of $1,641.29 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.19 per share, a decrease this year of $1.01 per share, and a decrease next year of $0.65 per share.
Berkshire Hathaway Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||